Edwards Lifesciences Corp 4
4 · Edwards Lifesciences Corp · Filed May 31, 2017
Insider Transaction Report
Form 4
Verguet Patrick B
CVP, Europe
Transactions
- Sale
Common Stock
2017-05-31$114.88/sh−10,000$1,148,760→ 129,137.15 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2017-05-31−10,000→ 38,800 totalExercise: $44.62From: 2012-05-12Exp: 2018-05-11→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2017-05-31$44.62/sh+10,000$446,150→ 139,137.15 total
Footnotes (2)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $114.7519 to $115.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.